Harry Glorikian, Author & General Partner at Scientia Ventures, dives into the current and future applications of AI and other innovative health technologies, including for personalized medicine, drug development, public health, disease prevention, and more. To find out more about Impetus: https://www.meetwithimpetus.com Natalie Yeadon LinkedIn: https://www.linkedin.com/in/natalieyeadon/ Impetus Digital Website: https://www.impetusdigital.com/ Impetus Digital LinkedIn: https://www.linkedin.com/company/impetus-digital/ Impetus Digital Twitter: https://twitter.com/impetus_digital Impetus YouTube: https://www.youtube.com/ImpetusDigital Harry Glorikian: https://www.linkedin.com/in/harryglorikian/ Scientia Ventures: https://www.scientiavc.com/